Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Full SNAP benefits must be paid ‘promptly,’ USDA tells states as government reopens - 2New electric car registrations rise sharply in Germany in March
- 3'Stranger Things' series finale trailer shows Hawkins gang gearing up for last battle with Vecna
- 4Images of Bangladeshi motorcyclists sleeping at petrol pumps are AI-generated
- 5The Reduced Portage Horse: An Inheritance Reconsidered for Present day Experience
- Iran steps up executions as experts warn state killing being used to suppress political dissent
- How to watch 'A Charlie Brown Christmas' for less with this Apple TV Black Friday deal
- Israel says it will keep control over part of southern Lebanon after war with Hezbollah ends
- 'Wicked: For Good' was filmed at this surreal National Park in Egypt
- Vote in favor of Your #1 BWM Vehicles
- Wegmans recalls mixed nuts over salmonella contamination fears
- 10 Setting up camp Shelters That Offer Both Excellence and Isolation
- Step by step instructions to Deal with Your Time While Chasing after an Internet based Degree
- Father and son spending Christmas together after health scares
